Key Points
- Intuitive Surgical EVP Myriam Curet sold 104 shares on Dec. 10 at an average price of $559.90 (≈$58,230), and previously sold 7,562 shares on Oct. 28 for about $4.15M.
- ISRG shares traded down ~1.3% to $548.44, with a 50-day/200-day moving average of $525.73/$505.69 and a market cap near $196.6B.
- The company recently beat expectations with $2.40 EPS (vs. $1.99) and $2.51B revenue, while analysts hold a consensus rating of "Moderate Buy" with an average price target of about $606.54.
Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Myriam Curet sold 104 shares of the company's stock in a transaction that occurred on Wednesday, December 10th. The stock was sold at an average price of $559.90, for a total transaction of $58,229.60. The sale was disclosed in a document filed with the SEC, which is available at the SEC website.
Myriam Curet also recently made the following trade(s):
- On Monday, November 10th, Myriam Curet sold 105 shares of Intuitive Surgical stock. The stock was sold at an average price of $560.00, for a total transaction of $58,800.00.
- On Tuesday, October 28th, Myriam Curet sold 7,562 shares of Intuitive Surgical stock. The shares were sold at an average price of $548.43, for a total value of $4,147,227.66.
- On Wednesday, October 29th, Myriam Curet sold 125 shares of Intuitive Surgical stock. The stock was sold at an average price of $543.00, for a total value of $67,875.00.
Intuitive Surgical Trading Down 1.3%
Shares of ISRG traded down $7.48 during trading hours on Thursday, hitting $548.44. 258,820 shares of the stock traded hands, compared to its average volume of 2,077,931. The business has a fifty day moving average of $525.73 and a 200-day moving average of $505.69. The firm has a market capitalization of $196.60 billion, a PE ratio of 72.53, a price-to-earnings-growth ratio of 5.13 and a beta of 1.68. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to analysts' expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The company's quarterly revenue was up 22.9% compared to the same quarter last year. During the same period in the previous year, the business posted $1.84 EPS. As a group, equities research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.
Wall Street Analysts Forecast Growth
Several research analysts have recently issued reports on ISRG shares. Leerink Partners raised their price target on Intuitive Surgical from $593.00 to $600.00 and gave the stock an "outperform" rating in a research report on Wednesday, October 22nd. Truist Financial set a $620.00 target price on Intuitive Surgical and gave the stock a "buy" rating in a report on Wednesday, October 22nd. UBS Group set a $600.00 price target on Intuitive Surgical and gave the company a "neutral" rating in a research note on Thursday, October 23rd. Jefferies Financial Group increased their price target on shares of Intuitive Surgical from $550.00 to $560.00 and gave the company a "hold" rating in a research report on Wednesday, October 22nd. Finally, Evercore ISI boosted their price target on shares of Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has an average rating of "Moderate Buy" and a consensus price target of $606.54.
Check Out Our Latest Stock Analysis on ISRG
Hedge Funds Weigh In On Intuitive Surgical
Several hedge funds have recently made changes to their positions in ISRG. Vanguard Group Inc. boosted its holdings in Intuitive Surgical by 0.8% during the third quarter. Vanguard Group Inc. now owns 33,599,661 shares of the medical equipment provider's stock worth $15,026,776,000 after purchasing an additional 263,828 shares during the last quarter. State Street Corp lifted its position in Intuitive Surgical by 1.2% during the 2nd quarter. State Street Corp now owns 15,552,203 shares of the medical equipment provider's stock worth $8,451,223,000 after buying an additional 182,871 shares in the last quarter. Geode Capital Management LLC boosted its stake in shares of Intuitive Surgical by 1.4% during the 2nd quarter. Geode Capital Management LLC now owns 8,188,685 shares of the medical equipment provider's stock worth $4,429,590,000 after buying an additional 109,904 shares during the last quarter. Capital World Investors boosted its stake in shares of Intuitive Surgical by 1.5% during the 3rd quarter. Capital World Investors now owns 7,728,492 shares of the medical equipment provider's stock worth $3,456,223,000 after buying an additional 116,034 shares during the last quarter. Finally, Norges Bank bought a new position in shares of Intuitive Surgical in the 2nd quarter valued at about $2,569,260,000. 83.64% of the stock is owned by institutional investors.
About Intuitive Surgical
(
Get Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
